A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Starting soon · Phase 1
Conditions studied: Healthy
In brief
This study is designed to determine the effect of ulonivirine (MK-8507) on methadone in the body. Participants will take methadone alone and then methadone with ulonivirine to see if ulonivirine changes how the body processes methadone.
Key facts
- Study ID
- NCT07595263
- Run by
- Merck Sharp & Dohme LLC
- People needed
- 14
- Starts
- 2026-08-17
- Expected to finish
- 2027-01-15
- Last updated by the study team
- 2026-06-23
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- The main Inclusion Criteria include but are not limited to:
- Is in good health
- Has a body mass index (BMI) between >18 and ≤40 kg/m\^2
- Is reliably participating in a methadone maintenance program for at least 2 months prior to Day 1 and is on a documented stable dose of methadone for at least 14 days prior to Day 1
You may not qualify if…
- The main Exclusion Criteria include but are not limited to:
- Has a history of cancer (malignancy)
- Has a history of significant multiple and/or severe allergies, or has had an anaphylactic reaction or significant intolerability to prescription or nonprescription drugs or food
- Has tested positive human immunodeficiency virus (HIV) or for a sexually transmitted infection at screening
- Is under the age of legal consent
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.